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ABSTRACT 
TITLE: CLINICAL EFFECTIVENESS OF SUBGINGIVALLY DELIVERED 
ROSUVASTATIN IN COMPARISON WITH ATORVASTATIN IN THE TREATMENT 
OF CHRONIC PERIODONTITIS 
Background: Periodontal disease occurs as a consequence of the host immune inflammatory 
response to oral pathogens. The treatment modalities available to achieve the goal of periodontal 
therapy includes scaling and root planing alone, or scaling and root planing with systemic or local 
antimicrobial/anti-inflammatory agents, and surgical periodontal therapy. This randomized, 
double blind, controlled clinical trial evaluates the efficacy of 1.2% Rosuvastatin in comparison 
with 1.2% Atorvastatin as local drug delivery in adjunct to scaling and root planing for the 
treatment of chronic periodontitis. 
 
Materials & Methods: Thirty patients requiring treatment for generalized chronic periodontitis 
were enrolled. They were divided into three groups of ten each.  One site per patient is selected for 
local drug delivery. Clinical parameters and Radiographs were also recorded at baseline and 6 
months.  
Results: The results obtained for the Atorvastatin and Rosuvastatin groups were comparable to 
that of the placebo group. This shows that the subgingival delivery of Atorvastatin and 
Rosuvastatin did not give any statistically significant improvement in the clinical and radiographic 
parameters after a period of 6 months.  
Conclusion: From the findings of the study, we elucidate that treating chronic periodontitis with 
subgingivally delivered Atorvastatin and Rosuvastatin as an adjunct to scaling and root planing 
did not demonstrate any positive results clinically as well as radiographically.  Keeping in mind 
the numerable research demonstrating the pleiotropic effects of statins further research need to be 
conducted on the effectiveness of in situ gel systems for the local drug delivery of statins. Ongoing 
and future investigations in this area should focus on establishing the molecular basis for the 
treatment of periodontal disease with statins by designing more stringently controlled 
interventional studies. 
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